Early or Late Booster in Basic Life Support for Health Care Professionals
NCT ID: NCT03893253
Last Updated: 2022-03-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
84 participants
INTERVENTIONAL
2018-10-22
2020-07-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early or Late Booster for Basic Life Support?
NCT02998723
Does Contextual Interference Improve Retention of Basic Life Support Skills? A Randomized Controlled Trial
NCT02381093
Self-learning vs Instructor-led Learning in BLS
NCT03141528
Does Instruction on Cognitive Aid Use Improve Performance and Retention of Skills?
NCT01646372
The Application of Intermittent Training in Clinical Skills Simulation Training
NCT07239531
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Early Booster Teaching
The early booster group will receive a booster teaching session at 3 weeks post-training followed by feedback.
Early Booster Teaching
The early booster group will receive a booster teaching session at 3 weeks post-training followed by feedback.
Late Booster Teaching
The late booster group will receive a booster teaching session at 2 months post-training followed by feedback.
Late Booster Teaching
The late booster group will receive a booster teaching session at 2 months post-training followed by feedback
Control group
The control group will receive no booster teaching at all.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Early Booster Teaching
The early booster group will receive a booster teaching session at 3 weeks post-training followed by feedback.
Late Booster Teaching
The late booster group will receive a booster teaching session at 2 months post-training followed by feedback
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* non healthcare professionals
* healthcare professionals who don't interact directly with patients
* healthcare professionals who have completed Basic Life Support training in the previous six months
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut du Savoir Montfort
UNKNOWN
Hopital Montfort
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Waldolf, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpital Montfort
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut du Savoir Montfort
Ottawa, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-19-08-020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.